Dihydrotestosterone is an endogenous androgen that is formed from testosterone via 5α-reductase activity in certain tissues including the prostate gland, seminal vesicles, epididymis, skin, hair follicles, liver, and brain.
DHT, relative to testosterone, is more potent as an agonist of the androgen receptor. Inhibition of 5α-reductase activity to reduce prostatic DHT levels is used to treat benign prostatic hyperplasia (BPH).
DHT has been used clinically as treatment for low testosterone levels in men. DHT is biologically important for sexual differentiation of the male genitalia during embryogenesis.
Circulating levels of DHT are low in relation to testosterone. Deficiency in 5α-reductase results in incompletely virilized males which is clinically supported by an elevated ratio of testosterone to DHT.
Every lab result you’ve ever had, charted and explained.
Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.
Start with my report →All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.